| Product NDC: | 68682-525 |
| Proprietary Name: | Fenofibrate |
| Non Proprietary Name: | Fenofibrate |
| Active Ingredient(s): | 48 mg/1 & nbsp; Fenofibrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68682-525 |
| Labeler Name: | Oceanside Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090715 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120625 |
| Package NDC: | 68682-525-01 |
| Package Description: | 90 TABLET in 1 BOTTLE (68682-525-01) |
| NDC Code | 68682-525-01 |
| Proprietary Name | Fenofibrate |
| Package Description | 90 TABLET in 1 BOTTLE (68682-525-01) |
| Product NDC | 68682-525 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fenofibrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120625 |
| Marketing Category Name | ANDA |
| Labeler Name | Oceanside Pharmaceuticals |
| Substance Name | FENOFIBRATE |
| Strength Number | 48 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |